A High Fat Diet Increases Bone Marrow Adipose Tissue (MAT) But Does Not Alter Trabecular or Cortical Bone Mass in C57BL/6J Mice

Journal of Cellular Physiology

Volumn 230, Issue 9, 2015, Pages 2032-2037

  Doucette, Casey R ^a,b   Horowitz, Mark C ^c   Berry, Ryan ^c   Macdougald, Ormond A ^d   Anunciado Koza, Rea ^a   Koza, Robert A ^a   Rosen, Clifford J ^a,b  

^a Maine Medical Center Research Institute   (United States)

^b UNIVERSITY OF MAINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICKKOPF 1 PROTEIN; FIBROBLAST GROWTH FACTOR 23; INSULIN; INTERLEUKIN 6; LEPTIN; OSMIUM; OSTEOCALCIN; OSTEOPROTEGERIN; SCLEROSTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE LENGTH; BONE MARROW; BONE MARROW ADIPOSE TISSUE; BONE MASS; BONE TURNOVER; CONTROLLED STUDY; CORTICAL BONE; DIAPHYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; LIPID DIET; LONGITUDINAL STUDY; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PILOT STUDY; PRIORITY JOURNAL; TRABECULAR BONE; ADVERSE EFFECTS; ANIMAL; BONE DEVELOPMENT; DRUG EFFECTS; ENERGY METABOLISM; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; OBESITY; PATHOLOGY;

MUS;

ADIPOSE TISSUE; ANIMALS; BONE DENSITY; BONE MARROW; DIET, HIGH-FAT; ENERGY METABOLISM; FEMALE; FEMUR; HUMANS; LEPTIN; MALE; MICE; OBESITY; OSTEOGENESIS;

EID: 84929832630     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24954     Document Type: Article

References (28)

1. Ackert-Bicknell C, Rosen C. 2006. The genetics of PPARG and the skeleton. PPAR Res 2006:93258.
2. Ackert-Bicknell CL, Shockley, KR, Horton, LG, Lecka-Czernik, B, Churchill, GA, Rosen, CJ. 2009. Strain-specific effects of rosiglitazone on bone mass, body composition, and serum insulin-like growth factor-I. Endocrinology 150:1330-1340.
3. Beamer WG, Schultz KL, Coombs, HF 3rd, DeMambro, VE, Reinholdt, LG, Ackert-Bicknell, CL, Canalis, E, Rosen, CJ, Donahue, LR. 2011. BMD regulation on mouse distal chromosome 1, candidate genes and response to ovariectomy or dietary fat. J Bone Miner Res 26:88-99.
4. Bonnet N, Somm E, Rosen CJ. 2014. Diet and gene interactions influence the skeletal response to polyunsaturated fatty acids. Bone 68:100-107.
5. Bornstein S, Brown, SA, Le, PT, Wang, X, DeMambro, V, Horowitz, MC, MacDougald, O, Baron, R, Lotinun, S, Karsenty, G, Wei, W, Ferron, M, Kovacs, CS, Clemmons, D, Wan, Y, Rosen, CJ. 2014. FGF-21 and skeletal remodeling during and after lactation in C57BL6 mice. Endocrinology 155:3516-3526.
6. Bredella MA, Fazeli, PK, Miller, KK, Misra, M, Torriani, M, Thomas, BJ, Ghomi, RH, Rosen, CJ, Klibanski, A. 2009. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab 94:2129-2136.
7. Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, Harrington LM, Breggia A, Rosen CJ, Miller KK. 2011. Determinants of bone mineral density in obese premenopausal women. Bone 48:748-754.
8. Cao JJ, Sun L, Gao H. 2010. Diet-induced obesity alters bone remodeling leading to decreased femoral trabecular bone mass in mice. Ann NY Acad Sci 1192:292-297.
9. Devlin MJ, Cloutier AM, Thomas NA, Panus DA, Lotinun S, Pinz I, Baron R, Rosen CJ, Bouxsein ML. 2010. Caloric restriction leads to high marrow adiposity and low bone mass in growing mice. J Bone Miner Res 25:2078-2088.
10. Dimitri P, King D, Paggiosi M, Walsh J, Bishop N, Eastell R. 2014. G59 bone microarchitecture and strength in obese children-A new insight into fracture risk. Arch Dis Child 99:A24-A25.
11. Duque G. 2008. Bone and fat connection in aging bone. Curr Opin Rheumatol 20:429-434.
12. Evans, EL, Paggiosi, MA, Eastell, R, Walsh, JS. 2014. Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood. J Bone Miner Res. Advance online publication. doi: 10.1002/jbmr.2407.
13. Harms M, Seale P. 2013. Brown and beige fat: Development, function and therapeutic potential. Nat Med 19:1252-1263.
14. Horowitz MC, Berry, R, Webb, R, Nelson, T, Xi, Y, Doucette, C, Fretz, JA, Church, CD, Rosen, CJ, Rodeheffer, M. 2014. Bone marrow adipocytes are distinct from white or brown adipocytes. Poster FR0066 presented at: American Society for Bone and Mineral Research Annual Meeting; Sep 12-15; Houston, TX.
15. Kajimura S, Seale, P, Tomaru, T, Erdjument-Bromage, H, Cooper, MP, Ruas, JL, Chin, S, Tempst, P, Lazar, MA, Spiegelman, BM. 2008. Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes Dev 22:1397-1409.
16. Lazarenko OP, Rzonca, SO, Hogue, WR, Swain, FL, Suva, LJ, Lecka-Czernik, B. 2007. Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone. Endocrinology, 148:2669-2680.
17. Le P, Kawai, M, Bornstein, S, DeMambro, VE, Horowitz, MC, Rosen, CJ. 2012. A high-fat diet induces bone loss in mice lacking the Alox5 gene. Endocrinology 153:6-16.
18. Lecka-Czernik B, Stechschulte, LA, Czernik, PJ, Dowling, AR. 2015. High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity. Mol Cell Endocrinol. Advance online publication. doi: 10.1016/j.mce.2015.01.001.
19. Nielson CM, Srikanth P, Orwoll ES. 2012. Obesity and fracture in men and women: An epidemiologic perspective. J Bone Miner Res 27:1-10.
20. Patsch JM, Kiefer, FW, Varga, P, Pail, P, Rauner, M, Stupphann, D, Resch, H, Moser, D, Zysset, PK, Stulnig, TM, Pietschmann, P. 2011. Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet-induced obesity. Metabolism 60:243-249.
21. Premaor MO, Pilbrow, L, Tonkin, C, Parker, RA, Compston, J. 2010. Obesity and fractures in postmenopausal women. J Bone Miner Res 25:292-297.
22. Rosen CJ, Klibanski A. 2009. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med 122:409-414.
23. Rosen CJ, Ackert-Bicknell, CL, Adamo, ML, Shultz, KL, Rubin, J, Donahue, LR, Horton, LG, Delahunty, KM, Beamer, WG, Sipos, J, Clemmons, D, Nelson, T, Bouxsein, ML, Horowitz, M. 2004. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Bone 35:1046-1058.
24. Ryan LM. 2010. Forearm fractures in children and bone health. Curr Opin Endocrinol Diabetes Obes 17:530-534.
25. Scheller EL, Troiano, N, Vanhoutan, JN, Bouxsein, M, Fretz, JA, Xi, Y, Nelson, T, Katz, G, Berry, R, Church, CD, Doucette, CR, Rodeheffer, MS, MacDougald, OA, Rosen, CJ, Horowitz, MC. 2014. Use of osmium tetroxide staining with microcomputerized tomography to visualize and quantify bone marrow adipose tissue in vivo. Methods Enzymol 537:123-139.
26. Skurk T, Alberti-Huber, C, Herder, C, Hauner, H. 2007. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92:1023-1033.
27. Wei W, Wang, X, Yang, M, Smith, LC, Dechow, PC, Sonoda, J, Evans, RM, Wan, Y. 2010. PGC1a mediates PPARG activation of osteoclastogenesis and rosiglitazone-induced bone loss. Cell Metab 11:503-516.
28. Zaidi M, Buettner, C, Sun, L, Igbal, J. 2012. Minireview: The link between fat and bone: Does mass beget mass? Endocrinology 153:2070-2075.